| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |